For the first time, these findings demonstrate the tumor-promoting role of SCAMP3 in TNBC and its association with EGFR and other receptor tyrosine kinases and expose the potential to develop SCAMP3-targeted anticancer therapies to increase patient survival. The gene discussed is EGFR; the disease is neoplasm.